Facing Patent Losses, Astellas Funds Genome Laboratory And Reorganizes Drug Discovery Functions
This article was originally published in PharmAsia News
Executive Summary
Astellas announced Sept. 1 it established the Genome Medical Science Laboratory at the University of Tokyo. The laboratory is looking to elucidate the mechanism of tumorigenesis through a large analysis of clinical samples using genomics technologies to develop new cancer treatments